why choose us

First received: November 20, 2023

Clinical Trial: Cell-Free DNA CHIP for Diagnosing Cancer

Study Status: Completed

Recruit Status: RECRUITING

Condition: Cancer of Pancreas

Study Type: OBSERVATIONAL


Official Title: Cell-free Chromatin Immunoprecipitation (CfChIP) From Blood Plasma as a Diagnostic and Prognostic Tool in Pancreatic Ductal Adenocarcinoma

Brief Summary: The goal of this research is to use chromatin immunoprecipitation, a method used to study protein-DNA interaction, as a tool to diagnose and prognose pancreatic ductal adenocarcinoma in human samples.This is a Non-Human Subject Research study.All participants are de-identified.

Read more